RxDoctor Payments Data
★ My doctorsLook up a doctor →

Neal Chawla

Hematology & Oncology · Santa Monica, CANPI 1669906665

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,179 of the $6,577 with a category attached, or 78.7%. It is spread thinly across 44 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations.

$6,577in general payments, 2019–2025

Across 189 payments — averaging $34.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$1K
  • Ipsen Biopharmaceuticals, Inc$538
  • Aadi Bioscience, Inc.$422
  • Astellas Pharma US Inc$419
  • AstraZeneca$387
  • Daiichi Sankyo Inc.$324
  • plus $3K from 38 others
$59,391in research payments, 2019–2025

Across 3 payments — averaging $19,797 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Coherus Oncology, Inc.$59K

What the payments were for

  • Consulting fees$1,00115%
  • Speaking & faculty fees$240%
  • Food & beverage$5,17979%
  • Education$3736%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Bayer7$1,169
Ipsen Biopharmaceuticals, Inc11$538
Aadi Bioscience, Inc.9$422
Astellas Pharma US Inc13$419
AstraZeneca(2 entities)15$387
Daiichi Sankyo Inc.16$324
Incyte Corporation12$313
E.r. Squibb & Sons, L.L.C.16$301
Merck9$244
AbbVie5$219
Springworks Therapeutics, Inc.9$195
Exelixis Inc.1$175
Sanofi3$165
Novartis7$163
Takeda Pharmaceuticals U.S.A., Inc.4$137
Boehringer Ingelheim5$129
Caris MPI, Inc.2$110
Lilly USA, LLC4$110
Pfizer3$91
Deciphera Pharmaceuticals Inc.4$83
Coherus Oncology, Inc.4$83
Gilead1$81
Agios Pharmaceuticals, Inc.2$55
Genmab U.S., Inc.2$54
Puma Biotechnology, Inc.2$51
Progenics Pharmaceuticals, Inc.2$46
Spectrum Pharmaceuticals Inc.1$43
ADC Therapeutics America, Inc.2$42
Helsinn Therapeutics (U.S.), Inc.2$40
Acrotech Biopharma Inc.1$35
Karyopharm Therapeutics Inc.1$34
Catalyst Pharmaceuticals, Inc.1$34
Organon1$33
Johnson & Johnson1$28
Jazz Pharmaceuticals Inc.1$28
Iovance Biotherapeutics, Inc.2$25
Invivyd Inc1$25
Dendreon Pharmaceuticals LLC1$23
Bristol Myers Squibb1$23
Pharmaessentia USA Corporation1$22
Recordati_rare_diseases_inc.1$22
Array Biopharma Inc1$21
Sobi, Inc1$17
Beone Medicines USA, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,577 in reported general payments places this provider in the 60th percentile of 1,363 hematology & oncology providers in California.

See all hematology & oncology providers in California →

Other hematology & oncology in Santa Monica

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →